期刊文献+

Netherton综合征及红斑型天疱疮表皮中激肽释放酶相关肽酶和丝氨酸蛋白酶抑制物的检测 被引量:1

Detection of KLKs and Serpins in the Epidermis of Netherton Syndrome and Pemphigus Erythematosus
下载PDF
导出
摘要 目的探讨激肽释放酶相关肽酶家族(KLKs)和丝氨酸/半胱氨酸蛋白酶抑制物(Serpins)在Netherton综合征(NS)及红斑型天疱疮(PE)患者表皮中的表达。方法选用LEKTI,SLPI,KLK5,KLK7的羊抗人多克隆抗体,以免疫组织化学结合图像分析软件进行半定量分析的方法研究NS,PE患者表皮中KLK5,KLK7,LEKTI,SLPI等的表达情况。结果NS组表皮中KLK5,KLK7,SLPI平均光密度分别高于对照组141.49%,523.88%,134.20%。PE组的KLK5,KLK7,SLPI平均光密度分别高于对照组90.73%,456.42%,77.11%。结论NS和PE表皮中KLK5,KLK7升高,而SLPI则代偿性上调。 Objective To investigate the characteristics of KLKs and Serpins in the epidermis of Netherton syndrome (NS) and pemphigus erythematosus (PE) patients. Methods The expression of LEKTI, SLPI, KLKS, KLK7 were studied in the epidermis of NS and PE with immnnohistochemistry and semi-quantitative analysis with image-pro plus 6.0. Results the mean density of KLKS, KLK7, SLPI in NS group was higher than that in control group by 141.49%, 523.88%, 134.20% respectively. In PE group, the mean density of KLKS, KLK7, SLPI was 90.73%, 456.42%, 77.11% higher than that in control group. Conclu- sion Expression level of KLK5 and KLK7 increased in NS and PE. and SLPI increased as well.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2009年第9期544-546,共3页 The Chinese Journal of Dermatovenereology
基金 北京大学第一医院院青年基金资助
关键词 激肽释放酶相关肽酶 丝氨酸/半胱氨酸蛋白酶抑制物 Netherton综合征 红斑型天疱疮 表皮屏障 KLKs Serpins Netherton syndrome Pemphigus erythematosus Epidermal barrier
  • 相关文献

参考文献9

  • 1BORGONO C A,DIAMANDIS E P.The emerging roles of human tissue kallikreins in cancer[J].Nat Rev Cancer,2004,4(11):876-890.
  • 2CAUBET C,JONCA N,BRATTSAND M,et al.Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family,SCTE/KLK5/hK5 and SCCE/KLK7/hK7[J].J Invest Dermatol,2004,122(5):1235-1244.
  • 3BORGONO C A,MICHAEL I P,KOMATSU N,et al.A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation[J].J Biol Chem,2007,282(6):3640-3652.
  • 4STEFANSSON K,BRATTSAND M,NY A,et al.Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum[J].Biol Chem,2006,387(6):761-768.
  • 5SMITH P K,HARPER J I.Serine proteases,their inhibitors and allergy[J].Allergy,2006,61(12):1441-1447.
  • 6EMAMI N,DIAMANDIS E P.New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family[J].Molecular Oncology,2007,(1):269-287.
  • 7CHAVANAS S,BODEMER C,ROCHAT A,et al.Mutations in SPINK5,encoding a serine protease inhibitor,cause Netherton syndrome[J].Nat Genet,2000,25(2):141-142.
  • 8SANTIN A D,CANE S,BELLONE S,et al.The serine protease stratum corneum chymotryptic enzyme (kallikrein 7) is highly overexpressed in squamous cervical cancer cells[J].Gynecol Oncol,2004,94(2):283-288.
  • 9SCHMID M,FELLERMANN K,FRITZ P,et al.Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease[J].J Leukoc Biol,2007,81(4):907-915.

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部